CClinicalTrials.gg
RecruitingNCT04729504Updated Dec 18, 2025

Cultural Adaptation of a SSI for Youth Anxiety

An interventional study of Adapted Project BRAVE in Anxiety Disorders, sponsored by University of Miami. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-18.

Sponsored by University of Miami · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Mar 2021; still recruiting 5 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The overarching objective of this protocol is to (1) adapt and (2) disseminate an evidence-based, brief (approximately 30 minute) single session intervention (SSI) to better reflect the cultural and linguistic diversity of Latin, Haitian, and Haitian-American individuals via a fully online platform.

02

Conditions studied

  • Anxiety Disorders

Browse trials for

03

In context

Anxiety Disorders

4,864 studies on the registry are indexed under Anxiety Disorders; 1,388 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 80 across 4,170 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of Miami is the lead sponsor of 820 studies on the registry; 161 are open to participants now.

Of its 111 completed or terminated interventional studies of FDA-regulated products, 93 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Be caregivers (e.g. biological or adoptive parent, or legal guardian) of a child age 4-10.
  2. Affirm that they have read the consent language and study overview on REDCap by checking a box.

Exclusion criteria

Exclusion Criteria:

- Not meet all of the inclusion criteria.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
2,000 participants (estimated)

Study arms

  • Other
    Adapted Project BRAVE Group

    Participants in this group will receive a single session intervention of a culturally and linguistically adapted Project BRAVE.

    Behavioral: Adapted Project BRAVE

Interventions

  • BehavioralAdapted Project BRAVE

    A culturally and linguistically adapted Project BRAVE is web-based single session intervention that is about 30 minutes in length. The session is designed to focus on targeting child anxiety symptoms in the multilingual and diverse families in Miami-Dade.

06

What researchers measure

Primary outcomes

  1. Change in anxiety as measured by GAD-2

    Generalized Anxiety Disorder 2-item (GAD-2) Scale has a total score ranging from 0 to 6 with a score of 3 being the cut-off for identifying possible cases and in which further diagnostic evaluation for generalized anxiety disorder is warranted.

    Time frame: Baseline, 2 weeks

  2. Change in anxiety as measured by the FASA

    Family Accommodation Scale - Anxiety (FASA) is a 9-item scale of measuring caregiver accommodation behaviors (modification of routines, facilitating avoidance, etc.) in light of youth anxiety. It has a total score ranging from 0 to 36 with the higher score indicating more frequent parental accommodation.

    Time frame: Baseline, 2 weeks

  3. Program Feedback Scale (PFS) Scores

    The PFS is a reliable, valid measure of the perceived acceptability of single-session interventions. It asks participants to rate acceptability and feasibility of an SSI they just completed. It has a total score ranging from 0 to 28 with the higher score indicating perceived acceptability and feasibility of the program.

    Time frame: 2 weeks

Secondary outcomes

  1. Perceived Change in Problem-Solving, and Preparedness to Manage Distress

    Two questions (Schleider et al., 2020) will be used to assess change in ability to solve problems, and ability to manage distress. Participants will be asked, "to what extent are you able to solve the problems \[with your child's anxiety\] facing right now?", and "how prepared do you feel to manage \[your child with\] distressing situations?" It has a total score ranging from 2 to 10, with a higher score indicating better ability to solve problems, and to manage distress.

    Time frame: 2 weeks

  2. Change in State Hope Scale Scores

    State Hope Scale is a 6-item self-report scale designed to evaluate hope in adolescents and adults, including two reliable subscales: agency and pathways. It has a total score ranging from 6 to 48 with the higher scores representing higher hope levels.

    Time frame: Baseline, 2 weeks

07

Study locations

1 of 1 sites recruiting
  • University of Miami
    Miami, Florida 33136, United States
    • Hannah Grassie · Contact · hlg54@miami.edu · 305-284-2712
    • Jill Ehrenreich-May · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04729504
Lead sponsor
University of Miami
Responsible party
Jill May Ehrenreich (Professor, Department of Psychology, University of Miami) — Principal investigator
First posted
Jan 28, 2021
Start date
Mar 8, 2021
Primary completion
Dec 21, 2026 (estimated)
Completion
Dec 21, 2026 (estimated)
Last update
Dec 18, 2025

Study contacts

Hannah Grassie, BA
Contact
hlg54@miami.edu
305-284-2712
Jill Ehrenreich-May
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion